GAMMA Investing’s Evolent Health EVH Stock Holding History

GAMMA Investing’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.1K	Buy	2,901 +175	+6%	+$776	﹤0.01%	3330
2026 Q2	$14.8K	Buy	2,726 +11	+0.4%	+$42	﹤0.01%	3007
2026 Q1	$6.19K	Buy	2,715 +1,400	+106%	+$4.44K	﹤0.01%	3292
2025 Q4	$5.26K	Buy	1,315 +1,207	+1,118%	+$6.71K	﹤0.01%	3253
2025 Q3	$914	Sell	108 -620	-85%	-$6.02K	﹤0.01%	3630
2025 Q2	$8.2K	Sell	728 -270	-27%	-$2.48K	﹤0.01%	2907
2025 Q1	$9.45K	Buy	998 +814	+442%	+$8.22K	﹤0.01%	2770
2024 Q4	$2.07K	Sell	184 -1,401	-88%	-$24.6K	﹤0.01%	3206
2024 Q3	$44.8K	Buy	1,585 +1,556	+5,366%	+$40.1K	﹤0.01%	1567
2024 Q2	$554	Buy	29 +8	+38%	+$204	﹤0.01%	3194
2024 Q1	$689	Hold	21	–	–	﹤0.01%	3028
2023 Q4	$618	Buy	+21	New	+$594	﹤0.01%	2915

Other funds holding EVH

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's EVH Position: Q3 2026 in Review

GAMMA Investing increased its Evolent Health (EVH) stake by 6.4% in Q3 2026, buying an estimated $776 and bringing the position to 2,901 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3330.

GAMMA Investing first reported a position in EVH in Q4 2023 and has held it in 12 quarters since. The position peaked at $44.8K in Q3 2024. 4 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

GAMMA Investing held 2,901 shares of Evolent Health worth $10.1K as of Q3 2026.
GAMMA Investing bought 175 Evolent Health shares in Q3 2026, an estimated $776.
Evolent Health made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3330 holding.
GAMMA Investing first reported a position in Evolent Health in Q4 2023 and has held it in 12 quarters since.
GAMMA Investing's Evolent Health position peaked at $44.8K in Q3 2024.
4 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.